$14.78
-0.39-2.57%
Last update: Nov 6, 8:38 AM

The average analyst price target for XP is $25.36, 69.5% above the current price. Of 9 analysts, 7 rate it Buy and 2 Hold. Targets range from $15 to $38. The latest change came on Nov 5, 2026, when UBS lowered its price target on XP from $37 to $23 and kept a Buy rating.
Price Target Range — 13 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months